|
Disclaimer:
Whonamedit.com does not give medical advice.
This survey of medical eponyms and the persons behind them is meant as a general interest site only. No information found here must under any circumstances be used for medical purposes, diagnostically, therapeutically or otherwise. If you, or anybody close to you, is affected, or believe to be affected, by any condition mentioned here: see a doctor.
|
A recommendation:
Hypography is an open community about science and all things related
|
|
|
Hallervorden-Spatz syndrome
Also known as:
Hallervorden-Spatz disease
Gilman and Barrett neuroaxonal dystrophy type I
Associated persons:
Robert E. Barrett
Sid Gilman
Julius Hallervorden
Hugo Spatz
Description:
A very rare disease beginning in childhood, with degeneration of the globus pallidus, red nucleus, and reticular part of the substantia nigra of the brain. It is characterized by progressive Parkinson-like rigidity, athetotic movements, and progressive mental and emotional retardation. Onset is in late childhood; death usually occurs within 10 years, but courses of up to 30 years have been described. Aetiology unknown; considered one form of iron storage disease. A heredo-familial syndrome, inherited as an autosomal recessive trait; some unrelated cases reported
The original description concerned a sibship of 12 in which 5 sisters showed clinically increasing dysarthria and progressive dementia, and at autopsy brown discoloration of the globus pallidus and substantia nigra.
Bibliography:
- J. Hallervorden, H. Spatz:
Eigenartige Erkrankung im extrapyramidalen System mot besonderer Beteiligung des Globus pallidus und der Substantia nigra: Ein Beitrag zu den Beziehungen zwischen diesen beiden Zentren.
Zeitschrift für die gesamte Neurologie und Psychiatrie, 1922, 79: 254-302.
- S. Gilman, R. E. Barrett:
Hallervorden-Spatz disease and infantile neuroaxonal dystrophy: Clinical characteristics and nosological considerations.
Journal of Neurological Sciences, Amsterdam, 1973, 19: 189-205.
|
|
|
